Memphis Startup Proof Positive of the Power of Everywhere Else

Lyme disease vaccine

Earlier this week Memphis-based US Biologic announced the successful field trials of it’s revolutionary Lyme disease vaccine. The vaccine, given to animals orally, creates antibodies that then attack the Lyme disease passed on from a tick bite.

Although the vaccine is being developed for animals, the company sees a connection between stopping the spread of Lyme disease in animals and doing the same for humans.

“The CDC has long-acknowledged a ‘One Health’ approach to preventing infectious diseases by linking animal and human treatments,” says US BIOLOGIC board director Tom Monath, MD. “US BIOLOGIC’s oral bait vaccine is an important example of how a vaccine for animals, in this case the white-footed mouse reservoir of Lyme disease, can break the Lyme disease transmission cycle.”

Lyme disease is no joke. According to the CDC, it affects over 300,000 people in the U.S. each year and can cause severe damage to joints and the neurologic system. The CDC also recently linked Lyme disease with several deaths due to cardiac disease.

What’s unique about US Biologic, though, is that they don’t plan on stopping at Lyme disease. The success of that vaccine proves that stopping diseases in animals will also help curb them in humans. They are essentially creating a platform from which they can develop treatments for any number of common diseases.

“The success of these field trials introduces a technology platform that can break the transmission of many diseases transmitted by animals,” says US BIOLOGIC board member David Williams, former Chairman & CEO of Sanofi Pasteur, the world’s largest vaccine provider. “Because of the large and growing number of cases, the focus on Lyme disease is a logical first step.”

Stories like that of US Biologic are what make “everywhere else” such a special place. We love all the technology that comes from Silicon Valley. Hey, we’re on Secret as much as the rest of you!

But it’s awesome to see what smart people outside the Valley are capable of, even if it’s not the sexiest new consumer app. I probably won’t be bragging to my friends that I just gave my cat the latest Lyme disease drug, but when it keeps my family healthy, I’m sure going to be grateful to US Biologic.

Memphis Startup Restore Medical Becomes First To 510 (K) Out Of Zero To 510 Accelerator

The ZeroTo510 startup accelerator in Memphis Tennessee is the first cohort-based medical device startup accelerator in the country. The joint venture between Start Co and Memphis Bioworks puts medical device companies through an accelerator program and helps shape scientists and engineers into startup founders.

The other, important goal for ZeroTo510 is getting these medical device startups to the 510(k) approval from the FDA. This approval is a quicker path to market roughly based on the idea that your product is expanding on an idea or improving an idea previously approved by the FDA. In short a typical FDA approval for a new device can take anywhere from 3-10 years while a 510 (k) approval can shorten that time down to 1-3 years.

All of the companies selected for the first two completed cohorts at ZeroTo510 (summer 2012 and summer 2013) werelooking to get that approval and get their product to market.

We’ve covered Restore Medical almost from the point when founders Shawn Flynn and Ryan Ramkhelawan made the move from Atlanta to Memphis for the accelerator at the beginning of summer 2012. At that time both founders told Nibletz that they liked Bioworks and the cohesiveness of the Memphis startup community, despite the fact that Atlanta is a much larger city.

Restore Medical has developed a system that more thoroughly, cleanly, cheaply and greenly sterilizes surgical instruments. The way surgical instruments are currently sterilized is time consuming. Not only that, but if one instrument is found to be unsterile the entire batch of instruments for a particular surgery needs to go through the process again. This can take hours at a time, so the OR teams must make a decision on whether to wake up the patient or to keep the patient under anesthesia which can be costly for the doctors and the patients not to mention dangerous.

“Our product allows hospitals to clean and re-sterilize surgical instruments more efficiently, saving time and money,” Flynn, the company President said in a statement. “More importantly, it improves the sterilization process, reducing the chances that a patient will be infected by contaminated instruments.

Restore Medical Solutions announced on Thursday that they had received their FDA 510(k) clearance. The company is also pleased to announced that it has successfully completed the certification process for internationally recognized medical device specific quality management standards ISO 13485:2003 and the Canadian Medical Device Conformity Assessment System (CMDCAS). Certification was conducted by BSI Group, one of the world′s leading certification bodies.

“These clearances allow us to market our products domestically and internationally, and they show that our product is safe, effective and meets regulatory requirements in both the United States and Canada,” said Ramkhelawan.

Restore Medical Solutions is moving into a larger 2500 square foot space in the Memphis Bioworks complex which will allow them space for assembly and distribution.

You can find out more about Restore Medical Solutions here.

Philly’s Novotorium Announces New Seed Funding Program

Philadelphia’s Novotorium continues to support health, wellness, and nutrition startups across the Philadelphia region. We’ve covered Novotorium quite a bit over the last 18 months and their progress has been fun to watch.

The team backing the startup support organization wants to get in with companies in their wheelhouse as early as possible, sometimes backing companies as early as a business plan stage or during the development of a companies minimum viable product (MVP). More often than not, companies at that early a stage are turned away and can’t develop without funding, especially in health and wellness sectors.

Novotorium has announced a week’s worth of programming geared towards the earliest stage companies. The program runs the week of September 16-20 and at the end of the week those that participated will be part of a business plan competition on September 23rd. The competition will have a $2500 prize, but Novotorium will consider all participants for possible future investments ranging from $5,000 to $250,000.

“Our goal with this program is to work with companies in the early stages of developing a business plan and creating the first iteration of their business. We are looking forward to helping them build out their plans and create their minimum viable products. We anticipate that we will be able to offer seed funding to several companies,” Novotorium Managing Director Stuart Segal said in a statement.

Novotorium’s Marketing and Business Director, Chuck Hall, summarized the program on their blog:

During each day of the week-long program — September 16 through 20 — Novotorium partners will be on hand at Novotorium in Langhorne to offer classes and hold office hours on key parts of creating and launching a business — finance, law, marketing, sales, operations, lean startup, agile development, technology, health care products and markets and more. This is a completely free week of sessions, with the goal of helping entrepreneurs accepted into this program move forward with their business plans and business implementation efforts.

On Friday, September 20, business plans and business development efforts will be vetted, with approved startups slotted into presentation times for Monday, September 23. Entrepreneurs will be asked to present to a Novotorium panel that will then determine the winner of the competition. The winner will receive the top prize of $2,500 in cash and $3,000 in services at Novotorium over a 30-day period.

Companies wishing to participate in the program must apply on the Novotorium website using the ordinary application form. Applicants should note “TBD” in any part of the application that is yet to be determined. Applicants should also note “Applying for September Program” in the “What Else?” section of the application.

Interested? Hit the application link above

Dallas Entrepreneur Launches HealthSparx Web Series On Startups & Innovation

HealtSparx,Michael Walsh,Dallas Startup,Health startup,startup podcast

(photo: meetup.com)

Dallas based entrepreneur Michael Walsh has been extremely busy lately. First off, his Austin Texas based startup, Cariloop, just launched. We interviewed Walsh about his startup that uses the “Expedia” model for geriatric care back in January.

Walsh also just recently launched a new web series called “HealthSparx”. This online web based radio show deals with the intersection of three important industries: health, technology and business.

Each webisode runs about 30 minutes and features commentary, information and an interview with an influential person in health or technology.

Healthsparx is already on it’s fourth webisode.

Episode #1 English majors rock as much as mechanical engineers

Episode #2 How IT plumbing will help healthcare

Episode #3 Every little bit helps in healthcare

Episode #4 Creating the perfect social and private experience

Walsh explains the three big reasons he decided to launch HealthSparx:

1. There is seriously so much cool stuff going on in healthcare right now that no one knows about, and that’s thanks to the innovative entrepreneurs and technology that are finally giving this industry the makeover it so desperately needs. Make no mistake, this makeover is going to take a LONG time for us to really see how great it looks, but we will get there…I am sure of it! I want to share these great stories from across the country and make people more aware of the cool products and services being born. If you have one of these stories for me, go submit your info to me on the “Be A Guest” page, I want to hear from you!

2. No easy way to say this, so I’ll just level with you…Healthcare has gotten ridiculously confusing. This confusion is affecting everyone – you, your business, your employees, on and on. I want to pull the curtain back a bit on what’s going on so you might finally make heads or tails of it. Maybe here, in the HealthSparx community, we can even come up with some things that the “powers that be” aren’t thinking about.

3. I love entrepreneurship – I love talking about entrepreneurs, I love helping entrepreneurs, and I love trying to light a spark within an entrepreneur who doesn’t yet know they are an entrepreneur. So, I’m going to do just that, bring people on the show that might be able to help someone else build that amazing idea they’ve been thinking about. This might include developers, designers, lawyers, financial advisors, investors, accelerators or any other people who think they know what it takes to bring a product or service to life. Take this information, digest it, and if possible, make something happen with it!

The shows are well produced and thought out and if you fit into one of HealthSparx categories feel free to apply to be a guest here.

There’s much more to Dallas than oil and JR, check out these Dallas startup stories here.

Are VC’s Bypassing Early Stage Health Deals?

Healthcare startups,Venture Capital,startups,funding,seed round,series a

(image: policymed.com)

Success stories, like the one of Memphis’ medical device accelerator Zeroto510, where 80% of their first class received follow on funding, seem to be growing scarce on a national scale. In their first class of six startups at the ZeroTo510 program 5 of the startups received follow on funding, with one, Restore Medical Solutions, going straight to a $2.5 million dollar series A round.

Well national medical startup publication MedCity News, released two graphs this morning that may be alarming to early stage medical startups, who often need a lot more seed money than your social, mobile, webtech startups.

The data, published by CB Insights, shows a significant number of VCs are skipping over earlier stage “seed round” deals for healthcare startups. Conversely, the same data set shows that the “series A crunch” may not be as prevalent in healthcare startups.

As you can see clearly from the data set Series A and Series B seem to be the preferred stage for a VC firm to get into a startup business, at least over the last five quarters.

According to MedCity News VC Funding in healtcare was up over the last year, in fact reaching a “multi year high”. Also worthy to note is that the medical device category is eating up the most VC funds. That should be good for the next round of ZeroTo510, Rock Health and Health Box.

Restore Medical talks to us about their $2.5 million dollar Series A round.

Tennessee Startup: MDSave Raising $1 Million To Connect Self Pays To The Best Care

A Brentwood Tennessee startup called MDSave is connecting self pay patients with a choice in healthcare that they hadn’t had before. Doctors who use the MDSave platform share their prices and extend deals to self pay patients and those with high deductible health insurance plans.

MDSave doesn’t only provide more options for those self pay patients, but in turn they help keep the emergency rooms and urgent care clinics less crowded. Perusing the MDSave website you can find that doctors are competing for those self pay patients so they keep their services affordable.

The doctors on the platform pay a small subscription fee. Patients on the other hand, use the platform to search for the type of medical service they need by zipcode. Once they’ve selected a participating doctor they pay in advance through the MDSave platform and they’re giving a voucher to see the doctor they selected. The voucher is redeemed at the appointment to cover the cost. This way, not only are self pay patients getting much needed healthcare the doctors are eliminating the risk associated with collections and the messy process it can be to collect from a self pay patient at the end of the appointment.

MedCitynews is reporting that a SEC filing has revealed that MDSave is in the middle of a $1 million dollar equity raise.

MDSave’s founder and CEO Paul Ketchel is a former member of former Tennessee US Senator Bill Frist. Ketchel is also the son in law of Tennessee Representative Marsha Blackburn.

According to MedCityNews the capital raised in this round will be used to expand MDSave outside of Tennessee.

Linkage:

Check out MDSave here

Source: MedCityNews

No one covers High Growth Technology in The South East like nibletz

Bring yourself to the largest startup conference in the US

Indianapolis Startup LabDoor Is The Consumer Reports For Medicine & Supplements

St. Louis born, young, serial entrepreneur Neil Thanedar has been flying under the radar lately while he’s been working on his latest startup project. We ran into him at one of the Verge Indy startup events in Indianapolis over the summer. While he couldn’t officially say what he was working on, he gave us a little taste off the record. We couldn’t wait until his idea came to fruition and we could take the wraps off. Well the time is now.

Thanedar moved to Indianapolis after meeting Scott Case at the legendary Mark Cuban Shark Tank Season 3 Premiere Party. Thanedar was working on a concept and in a 1:1 session Case, the two startup geniuses hashed out what’s become LabDoor today, an extremely easy to use “consumer reports for medicine and supplements”.

Thanedar, like his father, is a lifelong scientist and entrepreneur. Thanedar’s latest endeavor, LabDoor, is scientific at the core, but a consumer tool that will become invaluable over time.

In a nutshell what LabDoor does, is allows any consumer with their smartphone app, the ability to scan the barcode of pharmaceutical or supplement product A and compare it with pharmaceutical or supplement product B. How much different is that Albuteral inhaler than Ventolin or Proventil. What about Lipitor and it’s generic counterpart? What about the Vitamin B capsules from Walmart vs the Vitamin B capsules from CVS?

All of those are great questions you’ve probably wondered once or twice. Or at least you have your own similar questions.

LabDoor provides the easiest means to make sure you’re taking the right stuff.

We got a chance to talk with Thanedar who actually hurt our feelings earlier this week when he told us he though he was dead to us since he got accepted into the World Famous (valley based) Rock Health Accelerator. Actually we couldn’t be more proud of this brilliant entrepreneur, who is passionate about helping other founders anytime, anywhere.

Check out the interview below.

Memphis Startup: HandMinder Aims To Restore Hand Movement In Stroke Victims

There are some incredible startups coming out of Memphis Tennessee and HandMinder is one of them. Handminder was part of the first class at the ZeroTo510 accelerator. Zeroto510 is the first cohort based medical device accelerator and was a joint venture between Memphis BioWorks and Seed Hatchery, the local tech startup accelerator.

HandMinder was founded by Dr. Yu Liu, MD,Phd, Randall J Nelson PhD,John M Denton, Technical Advisor & CoFounder, James Bell who currently serves as the company’s CEO.

A shocking 15 million people suffer from strokes across the globe. 12.5 million of those people survive and of those 12.5 million, 60% of them have some form of hand dysfunction after the stroke.

The devices that are currently on the market today that help rehab stroke victims’ hands deal with the problem from a total physiological perspective. The devices today allow functionality but not learned functionality. They provide localized muscular exercise but not brain function.

The HandMinder device, which fits like a glove, restores the neurological connection between the hand and the brain. The loss of hand movement in a stroke victim is a neurological problem, not just a physiological problem. By reprogramming the stroke victims brain to hand function, HandMinder closes the natural physiological loop.

Unlike other devices that address this issue, HandMinder is a take home product that allows stroke victims to rehabilitate their hands as often as they would like without having to take up extra time in their rehab clinics. It also allows them to continue their therapy while traveling, being outside and living somewhat normal lives.

When designing the HandMinder product, the team at HandMinder talked with stroke victims and their families. Because strokes are more prevalent in older patients, Handminder even talked with grandparents and grandchildren who were concerned with the way some of the medical devices looked. A lot of other devices used for this purpose, seemed somewhat scary to grandchildren which was a real concern for older patients. Handminder, while still a medical device, “looks cool”.

HandMinder presented at the ZeroTo510 demo day last month to a crowd of investors. They are currently working on their third prototype and plan to start field testing the device shortly.

Linkage:

For more info visit handminder.com

Nibletz is the voice of startups “everywhere else” here are more startup stories from “everywhere else”

No one covers high growth startups in the SouthEast like nibletz, more here.

Austin Startup: Lumos Pharma To Develop & Prepare Autism Treatment Discovered In Cincinnati

There may be some great news for parents of Autistic boys in the coming years.

A research team at the University of Cincinnati has announced that they’ve successfully treated an animal model of Creatine Transporter Deficiency (CTD). CTD is what causes Autism in boys. Over 50,000 boys in the US are afflicted with CTD.

Creatine Transporter Deficiency causes symptoms including seizures, mental retardation and speech defects.

CTD was discovered at Children’s Hospital in Cincinnati in 2000. Almost all of the research on CTD has been performed at Children’s Hospital and at the University of Cincinnati.

This is actually a wonderful, tremendous Cincinnati-centric story,” Joe Clark the UC Neurology Professor who led the research team said to newsrecord.org.. “The disease was discovered at Children’s Hospital, the animal model of the disease was made here in Cincinnati by UC, and the drug was made to treat those mice here at Cincinnati.”

The research team found that cyclocreatine, which has been dubbed CincY, has been incredibly effective at reducing the symptoms of CTD models in animals.

Clark reported that the time from discovery in 2000 to the discovery of this possible treatment in just twelve years was actually a rather short time frame. While this work has been done on animals, it may be another two to three years befor CincY can be used to treat humans.

Clark is quick to point out that this is just a treatment for the disease and not a cure.

“Essentially, a cure is fixing a broken pipe at the break, and a treatment is making a bypass around the afflicted area without fixing it, but in a manner that eliminates the symptoms” Clark said.

Linkage:

Source: newsrecord.org

Nibletz is the voice of startups “everywhere else”

Xoogler Spotlight NYC Startup: Flatiron Health

In 2010 Nat Turner and Zach Weinberg sold their startup Invite Media to Google for $81 million dollars. At that time they were absorbed into Google where they spent the last two years. Now the co-founding team is back at it again, and navigating through unchartered territory.

Their new startup is New York City based Flatiron Health. FlatIron Health hopes to streamline cancer screening for clinical trials. Currently biomarkers among other diagnostics, are used to identify cancer patients for clinical trials however the team told Business Insider they feel that the process could be improved upon and streamlined.

“It’s actually very complicated to find out if you’re eligible,” Turner told SAI. “It’s like 120 variables and there’s no way to know quickly. We hope to speed that up for physicians because clinical trials are huge for cancer. In general, treatments fail and trials are the way to go.”

After both 26-year-old founders had loved ones suffer through cancer they knew their next mission would somehow be related to cancer. They admittedly don’t have their exact product yet however they’ve been holding weekly brainstorming sessions and have a pilot going with some of the major hospitals.

FlatIron Health is a far cry from the ad technology and bid manager platform Turner and Weinberg created with Invite Media. That platform allowed advertisers to manage online campaigns across multiple platforms.

Weinberg and Turner are in a better financial position than most new medical startups. They’re attacking this startup with the vigor of anxious entrepreneurs and aren’t intimidated by the fact that neither founder has any kind of background in medicine, biology or cancer.

“Flatiron Health is either going to be a great success or a horrible failure,” says Turner. “Hopefully we’ll do well by doing good.”

Linkage:

Here are some other Xoogler spotlights at nibletz.com

Source: Business Insider via Fierce

Kansas Startup: Lead Horse Technology Launches MedLoom Patient Safety Tool Interview

A Junction City Kansas startup called Lead Horse Technology has introduced a new patient safety tool that provides critical safety information to doctors providing patient care. Adverse reactions to medication can be life threatening in any setting, but especially in a hospital setting where doctors and nurses are charged with the care of several patients at one time. While the move to paperless charting is welcomed by all, it can actually open up risk factors such as adverse reactions to medication at an alarming rate.

Medloom, the tool created by Lead Horse Technology, is designed to be an add on for electronic health information systems and provides important medical patient safety information to doctors, nurses, technicians, pharmacists and anyone else who comes in contact with the patient and their electronic medical record (EMR).

Medloom provides pharmacovigilance (the ‘assessment and monitoring of the safety of drugs as used in the real world’) support to clinical decision-making. Unlike other “clinical decision support systems”, Medloom does not rely on published data but uses an advanced artificial intelligence algorithm to create ‘at risk’ profiles from the FDA’s adverse event reporting system, then cross-references these profiles with individual patient records to scan for those patients who match. Patient identity is never compromised or even an issue, because Medloom only looks at the patient profile (meds, background conditions, age and gender) and never captures patient ID.

In an initial clinical validation trial Medloom correctly identified 80% of the patients who were at risk for not just adverse reactions to medication but life threatening adverse reactions to medication.

We got a chance to interview Dr. Ramona Leibnitz, one of the co-founders of Lead Horse Technology about this exciting new medical startup. Check out the interview below.

Raleigh Startup: Sprout Scores $20M Round For Female Viagra

If you’re in a relationship with a woman, whether it’s a long term relationship, marriage, or even same sex marriage, and your female partner tells you she’s not in the mood, a lot, it may not be you after all. A Raleigh NC based startup called Sprout may actually be able to help you and your partner, down the road if they get FDA approval.

In 1998 Pfizer rocked the market when they introduced Viagra the first commercially available medication for men with erectile dysfunction. Viagra spawned a new category of prescription medications that have now turned into a $5 billion dollar industry. No one thought about women though.

Female sexual dysfunction, or low sexual desire is an actual problem. An Illinois based company called BioSante Pharmaceuticals suggests that as many as 43% of women between the ages of 18 and 59 experience some kind of female sexual dysfunction. The company made that statement based on figures published by the Journal of the American Medical Association. They project that female sexual dysfunction could turn into a $2 billion dollar a year industry.

Sprout, is working toward FDA approval for fibanserin a compound developed to treat hypoactive sexual disorder which is a form of female sexual dysfunction. Sprout purchased the compound from German pharmaceutical company Boehringer Ingelheim. The FDA denied Boehringer approval of fibanserin in 2010.

Sprout’s Chief Commercial Officer Cynthia Whitehead thinks that Sprout will be more successful with FDA approval. Whiethead told WRAL that there were “flawed metrics” in the first FDA submission by Boehringer. She went on to say “It will be a review issue,” she said. “We feel we have all of the data we need.”

Whitehead also said that Boehringer’s submission for fibarnserin was as a depression treatment.

Sprout has received a $20 million dollar angel investment from 59 angel investors, the same group of investors that backed Slate Pharmaceuticals which was the company that spun out Sprout. The company will use the money to support their operations and growth. They will also use the money to hire regulatory personnel and scientists to work on the resubmission of the drug in 2013.

Source: WRAL

Madison Startup: Moxe Health Applications – Triage.me

Triage.me is a solution for one of the biggest issues within the U.S. healthcare system – unnecessary trips to the Emergency Room. At the Milwaukee BuildHealth Hack-a-thon this idea was born from the challenge: “Reduce the number of ED (Emergency Department) visits for non-emergent care in Milwaukee County.”

We recently finished the second leg of our “Nibletz Sneaker Strapped Nationwide Road Trip.” We met Moxe Health’s CEO Dan Wilson while in Madison, his CTO was not available but I was able to find his description about how Triage.me works:

Providing people with the tools they need to find appropriate care everywhere saves everyone, hospitals and patients, money and time. Patients receive a SMS from triage.me post emergency room discharge. By sending a text to triage.me with their problem and current address, we route the person towards the nearest clinic, providing the address and a link to directions (for smartphone users). Many clinics that work with the underinsured also often have variable hours and locations. We’ve made it easy for these clinics to update their hours and location via SMS so that we can better route triage.me users to locations.

This is a huge issue that faces the current health care system, the CDC (Centers for Disease Control and Prevention) estimates that 50% of the 121 million emergency room visits in 2011 could have been handled in a primary care situation. The typical emergency room visit costs an average of $700 versus $150 for a primary care physician possibly reducing costs by $550.

We met Moxe Health’s Dan Wilson (CEO) while we were at Murfie HQ in Madison Wisconsin (coverage coming soon). He began explaining where the idea for triage.me began and where they’ve presented so far. It began at BuildHealth and a few weeks later they presented at Health Data Initiative: Health Datapalooza

A mere 50 days separated the two events and Dan blogged a few times about the experience:

Blog post 2…We’re now full steam ahead on triage.me and have some exciting things in store. Exactly 50 days after conceptual, triage.me will launch on June 5 for public use in Milwaukee and DC. We’ve started mapping out ways to expand triage.me to make it even better.

Blog post 3…So, we had 4 weeks to design a booth and rewrite an entire product. Oh, and Mark was already committed to working 30 hours a week in Chicago. We called in whatever favors we could muster and got some wonderful help from Abby Larner reworking the front-end design. Aurora stepped in to help with the booth and drove one of their display boards across the city so we could pick it up.

Where are we now? Mark and I are fully committed to building triage.me into the platform we know it can be. We’ve received a lot of positive feedback and guidance over the last few weeks and there ia a lot of thanks due.

Stay tuned, this ride’s just getting started!

Triage.me was presented at the Health Datapalooza (video below). Descriptions of both BuildHealth and HDI can be found below.

triage.me [Moxe Health] from HDI Forum on Vimeo.

BuildHealth is a context design for enabling collaborative conversation, engagement and accountability around the idea of good health.

Our definition of health is holistic: it is being physically, mentally, emotionally, economically, environmentally and socially balanced. With such a broad definition, the mission is currently focused on the Greater Milwaukee area in order to be effective. The core functions of the BuildHealth organization are facilitation and community alignment. Our intent is to avoid duplication of services, to overcome silo-ing and territorialization and to empower community at its most basic level. We believe each community already has what is needs to become accountable for its state of health.

Health Data Initiative’s: Health Datapalooza

The Health Data Initiative Forum III: The Health Datapalooza was held June 5 and 6, 2012, at the Walter E. Washington Convention Center in Washington, D.C. The event brought together a diverse group of more than 1,500 data experts, technology developers, entrepreneurs, policy makers, health care system leaders, and community advocates to support innovative applications of health and health care data.

Links to Everywhere Else:

Moxe Health Applications triage.me

Nibletz is the voice of startups “everywhere else” here are more stories from “everywhere else”

Nibletz could use YOUR help click here

DC HealthTech Startup MedClimate Presents At TechBUZZ

MedClimate, a DC area startup in the HealthTech field, presented last week at TechBUZZ as part of Capital Connection 2012.

MedClimate is looking to take a problem that many new and expectant parents face with doctors and that is, getting questions answered without increasing wait times in already packed waiting rooms. As Tim Barnes, Founder of MedClimate, points out in his pitch, everyone has experienced long waits at doctors offices.

What you may not have considered is that as information has become more and more available to patients, including new parents and expectant parents, wait times in waiting rooms are increasing because more patients are asking more questions. This definitely makes sense when you’re the parent, or patient, but never in the waiting room itself.

Through a disruptive approach to appointment management and using things like videos, video messaging, and making web and mobile appointments, medclimate hopes t o streamline care and make wait times less painful. They plan on doing this all and still allowing for an increase in patient/parent care questioning.

MedClimate plans to use video conferencing to allow patients to ask questions and get immediate feedback from their doctors from the comfort of their own home, or office, while still allowing the practitioner to collect payment via insurance.

The ultimate goal is to not affect everyones already busy schedule with unnecessary appointments.

Check out Barnes pitch below: